Save your place

Sign in to WhoBought

Please try again later.

Stanley Druckenmiller's BridgeBio Pharma, Inc. (BBIO) position

Not anymore: Stanley Druckenmiller fully exited BBIO in Q2 2025. The position peaked at an amount we cannot price in Q1 2025.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
438K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

BBIO price vs Druckenmiller's position

1Y 3Y 5Y MAX
Dates
$80$82$84$86← Earlier —1 purchase
Average closing price · filing quarter
—
Price range · filing quarter
—
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q2 2025 Exited −438K – −100.0% 0 Aug 15, 2025
Q1 2025 New +438K – – 438K May 15, 2025
Data through Q2 2025 · filed Aug 15, 2025
2 grouped rows from 2 quarters

More Druckenmiller positions

Natera, Inc.(NTRA)
$613M
20.9% of portfolio

Insmed Incorporated(INSM)
$189M
6.4% of portfolio

Taiwan Semiconductor Manufacturing Company Limited(TSM)
$167M
5.7% of portfolio

YPF Sociedad Anónima(YPF)
an amount we cannot price
5.1% of portfolio

BBB Foods Inc.(TBBB)
an amount we cannot price
3.7% of portfolio

Alcoa Corporation(AA)
$99M
3.4% of portfolio

Common questions

Does Stanley Druckenmiller own BBIO?

Not currently. Stanley Druckenmiller fully exited BBIO in Q2 2025, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Stanley Druckenmiller buy BBIO?

Stanley Druckenmiller first disclosed a BBIO position in Q1 2025; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Stanley Druckenmiller sell BBIO?

Yes. Stanley Druckenmiller reduced and then fully exited BBIO by Q2 2025; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of BBIO does Stanley Druckenmiller own?

None as of the latest filing: Stanley Druckenmiller has exited BBIO. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Stanley Druckenmiller pay for BBIO?

Stanley Druckenmiller began building the BBIO position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.